Synthesis and evaluation of [2-(4-quinolyloxy)phenyl]methanone derivatives: novel selective inhibitors of transforming growth factor-beta kinase
- J Med Chem. 2008 Jun 12;51(11):3326-9. doi: 10.1021/jm701626z.
- 1. KIRIN Pharma Co Ltd, Shibuya, Tokyo, Japan. [email protected]
We synthesized and evaluated various [2-(4-quinolyloxy)phenyl]methanone derivatives. These compounds had novel chemical structures that were distinct from those of previously reported inhibitors. Biological data suggested that these compounds inhibited transforming growth factor-beta signaling by interacting with the ATP-binding pocket of the transforming growth factor-beta type I receptor kinase domain. Here, we report on the synthesis and structure-activity relationships of the compounds in this series.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Others